| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.06. | Goldman Sachs initiates Lifestance Health stock at neutral | 1 | Investing.com | ||
| LIFESTANCE HEALTH GROUP Aktie jetzt für 0€ handeln | |||||
| 04.06. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 26.05. | Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now | 1 | Zacks | ||
| 12.05. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 08.05. | LifeStance Health Group prices secondary offering at $8.15 per share | 1 | Seeking Alpha | ||
| 08.05. | LifeStance Health prices secondary offering at $8.15 per share | 1 | Investing.com | ||
| 08.05. | LifeStance Health Group, Inc.: LifeStance Health Group Announces Pricing of Secondary Public Offering | 1 | GlobeNewswire (USA) | ||
| 07.05. | LifeStance: Aktionäre wollen 35 Millionen Aktien platzieren | 1 | Investing.com Deutsch | ||
| 07.05. | LifeStance stockholders plan 35M share offering | 1 | Investing.com | ||
| 07.05. | LifeStance Health Group, Inc.: LifeStance Health Group Announces Launch of Secondary Public Offering | 1 | GlobeNewswire (USA) | ||
| 07.05. | Lifestance forecasts $1.64B-$1.68B 2026 revenue while targeting mid-teens adjusted EBITDA margins by 2028 | 2 | Seeking Alpha | ||
| 07.05. | LifeStance hebt nach starkem ersten Viertel die Prognose an: Umsatz wächst um 21 % | - | Investing.com Deutsch | ||
| 07.05. | LifeStance Q1 2026 presentation: 21% revenue growth, guidance raised | 1 | Investing.com | ||
| 07.05. | LifeStance Health Group, Inc. Q1 Earnings Summary | 1 | RTTNews | ||
| 07.05. | LifeStance Health Group GAAP EPS of $0.04 beats by $0.03, revenue of $403.5M beats by $17.38M | 1 | Seeking Alpha | ||
| 07.05. | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | 409 | GlobeNewswire (Europe) | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| 28.04. | LifeStance Health: Aktie legt nach Ankündigung der Aufnahme in den S&P SmallCap 600 deutlich zu | 2 | Investing.com Deutsch | ||
| 28.04. | S&P Dow Jones Indices: LifeStance Health Group Set to Join S&P SmallCap 600 | 326 | PR Newswire | NEW YORK, April 27, 2026 /PRNewswire/ -- LifeStance Health Group Inc. (NASD: LFST) will replace Golden Entertainment Inc (NASD: GDEN) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| 06.03. | Barclays raises Lifestance Health stock price target on growth outlook | 12 | Investing.com | ||
| 02.03. | LifeStance Health Group, Inc. - 8-K, Current Report | 1 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 39,310 | +0,69 % | DAX-Check LIVE: Auto1, BMW, Fresenius, Munich Re, Vonovia im Fokus | Der deutsche Aktienmarkt hat den Dienstag nur mit einem Mini-Plus beendet. Der DAX, der am Morgen noch über 25.100 Punkten notiert hatte, schloss am Ende lediglich 0,07 Prozent fester bei 24.910 Zählern.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,260 | -0,29 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,430 | -0,63 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 24,840 | -1,43 % | Carl Zeiss Meditec AG: ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing | ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining... ► Artikel lesen | |
| TELADOC HEALTH | 7,034 | -0,20 % | Teladoc Health extends rally to seventh straight session | ||
| EUROFINS SCIENTIFIC | 62,70 | -0,41 % | Eurofins Scientific: Director/PDMR Shareholding | EUROFINS SCIENTIFIC: DIRECTOR/PDMR SHAREHOLDING
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 39,690 | +0,42 % | Truist Reiterates Buy Rating for Boston Scientific (BSX) | ||
| DEXCOM | 63,20 | -0,32 % | Dexcom Scores Pediatric Expansion For OTC Stelo Glucose Monitor | ||
| ALIGN TECHNOLOGY | 157,80 | -0,66 % | Is Align Technology Stock Underperforming the Dow? | ||
| INMODE | 11,675 | 0,00 % | InMode Ltd. - 6-K, Report of foreign issuer | ||
| INVITAE | - | - | Patentstreit: Natera sichert sich 30 % Lizenzgebühr von Invitae | ||
| PETMED EXPRESS | 1,480 | +1,44 % | PetMed Express, Inc.: PetMeds Announces Fourth Quarter and Fiscal Year 2026 Financial Results | DELRAY BEACH, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its fourth quarter and... ► Artikel lesen | |
| TANDEM DIABETES | 13,500 | +0,75 % | Girteka-Tochter TNDM Trucking: Warum der Billigpreis nicht mehr reichen soll | ||
| ORGANON | 11,700 | -0,17 % | Samsung Bioepis and Organon Expand Agreement to Commercialize PYZCHIVA, a Biosimilar Referencing STELARA in Canada | ||
| INSULET | 126,50 | -0,51 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen |